Daiwa Securities Group Inc. - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 134 filers reported holding IMMUNITYBIO INC in Q3 2023. The put-call ratio across all filers is 1.30 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$3
-25.0%
1,6100.0%0.00%
Q2 2023$4
+33.3%
1,6100.0%0.00%
Q1 2023$3
-62.5%
1,6100.0%0.00%
Q4 2022$8
-99.9%
1,610
+8.6%
0.00%
Q3 2022$7,000
-92.6%
1,483
-94.2%
0.00%
-100.0%
Q2 2022$95,000
-24.6%
25,589
+14.1%
0.00%0.0%
Q1 2022$126,000
+31.2%
22,432
+42.4%
0.00%0.0%
Q4 2021$96,000
+68.4%
15,756
+170.7%
0.00%
Q3 2021$57,000
+418.2%
5,820
+680.2%
0.00%
Q2 2021$11,000
+120.0%
746
+245.4%
0.00%
Q1 2021$5,0002160.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$4,180,0000.56%
HARBOURVEST PARTNERS LLC 335,709$2,041,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$586,0000.20%
SHEETS SMITH WEALTH MANAGEMENT 152,276$926,0000.12%
GSA CAPITAL PARTNERS LLP 129,260$786,0000.10%
Clearwater Capital Advisors, LLC 140,551$855,0000.09%
Virtus ETF Advisers LLC 28,969$176,0000.07%
XTX Topco Ltd 19,159$116,0000.07%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 49,464$301,0000.04%
Vident Investment Advisory, LLC 168,476$1,024,0000.03%
View complete list of IMMUNITYBIO INC shareholders